• The safety and immunogenicity of a fourth dose of NVX-CoV2373

    12 days ago - By News Medical

    Researchers assessed the immunogenicity and safety of a fourth homologous boost dose of a recombinant SARS-CoV-2 spike protein vaccine called NVX-CoV2373.
    Read more ...